Inhibition of osteoclastogenesis for periprosthetic osteolysis therapy through the suppression of p38 signaling by fraxetin

Liao,Jia‑Cheng; Wei,Zhao‑Xia; Zhao,Chang; Ma,Zhong‑Ping; Cai,Dao‑Zhang

doi:10.3892/ijmm.2018.3698

Inhibition of osteoclastogenesis for periprosthetic osteolysis therapy through the suppression of p38 signaling by fraxetin

Authors:
- Jia‑Cheng Liao
- Zhao‑Xia Wei
- Chang Zhao
- Zhong‑Ping Ma
- Dao‑Zhang Cai
View Affiliations

Affiliations: Department of Orthopedics, Southern Medical University Affiliated People's Hospital of Longhua District Shenzhen, Shenzhen, Guangdong 518109, P.R. China, Department of Neurology, Liwan Hospital of The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510000, P.R. China, Department of Orthopedics, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510630, P.R. China, Department of Orthopedics, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia 510030, P.R. China
Published online on: May 21, 2018 https://doi.org/10.3892/ijmm.2018.3698
Pages: 1257-1264
Copyright: © Liao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Periprosthetic osteolysis belongs to osteolytic diseases, which often occur due to an imbalance between osteoclast and osteoblast number or activity. Fraxetin, a natural plant extract, inhibits osteoblast apoptosis and has therapeutic potential for treating osteolytic diseases. However, data pertaining to the effects of fraxetin on osteoclasts are limited. In the present study, it was demonstrated that the inhibition of osteoclastogenesis by fraxetin had an important role on the therapy of titanium particle‑induced osteolysis in vivo. In addition, fraxetin was demonstrated to suppress receptor activator of nuclear factor‑κB ligand (RANKL)‑mediated osteoclast differentiation and bone resorption in vitro in a dose‑dependent manner. Fraxetin inhibited osteoclast differentiation and function through the suppression of p38 signaling and subsequently, the suppression of osteoclast‑specific gene expression, including tartrate‑resistant acid phosphatase, nuclear factor of activated T‑cells, cytoplasmic 1, and cathepsin K. In conclusion, fraxetin administration may have potential as a treatment method for periprosthetic osteolysis and other osteolytic diseases.

View Figures

View References

1	Teitelbaum SL: Bone resorption by osteoclasts. Science. 289:1504–1508. 2000. View Article : Google Scholar : PubMed/NCBI
2	Rodan GA and Martin TJ: Therapeutic approaches to bone diseases. Science. 289:1508–1514. 2000. View Article : Google Scholar : PubMed/NCBI
3	Helfrich MH: Osteoclast diseases and dental abnormalities. Arch Oral Biol. 50:115–122. 2005. View Article : Google Scholar : PubMed/NCBI
4	Abu-Amer Y, Darwech I and Clohisy JC: Aseptic loosening of total joint replacements: Mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther. 9(Suppl 1): S62007. View Article : Google Scholar : PubMed/NCBI
5	Anderson JM, Rodriguez A and Chang DT: Foreign body reaction to biomaterials. Semin Immunol. 20:86–100. 2008. View Article : Google Scholar
6	Long M and Rack HJ: Titanium alloys in total joint replacement-a materials science perspective. Biomaterials. 19:1621–1639. 1998. View Article : Google Scholar : PubMed/NCBI
7	Holt G, Murnaghan C, Reilly J and Meek RM: The biology of aseptic osteolysis. Clin Orthop Relat Res. 460:240–252. 2007.PubMed/NCBI
8	Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ and Suda T: Origin of osteo-clasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA. 87:7260–7264. 1990. View Article : Google Scholar
9	Novack DV: Role of NF-kappaB in the skeleton. Cell Res. 21:169–182. 2011. View Article : Google Scholar
10	Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature. 423:337–342. 2003. View Article : Google Scholar : PubMed/NCBI
11	Feng X: RANKing intracellular signaling in osteoclasts. IUBMB Life. 57:389–395. 2005. View Article : Google Scholar : PubMed/NCBI
12	Witaicenis A, Seito LN, da Silveira Chagas A, de Almeida LD Jr, Luchini AC, Rodrigues-Orsi P, Cestari SH and Di Stasi LC: Antioxidant and intestinal anti-inflammatory effects of plant-derived coumarin derivatives. Phytomedicine. 21:240–246. 2014. View Article : Google Scholar
13	Murali R, Srinivasan S and Ashokkumar N: Antihyperglycemic effect of fraxetin on hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Biochimie. 95:1848–1854. 2013. View Article : Google Scholar : PubMed/NCBI
14	Kuo PL, Huang YT, Chang CH and Chang JK: Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-alpha and interleukin-1beta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63. Int Immunopharmacol. 6:1167–1175. 2006. View Article : Google Scholar : PubMed/NCBI
15	Jin S, Park JY, Hong JM, Kim TH, Shin HI, Park EK and Kim SY: Inhibitory effect of (-)-epigallocatechin gallate on titanium particle-induced TNF-alpha release and in vivo osteolysis. Exp Mol Med. 43:411–418. 2011. View Article : Google Scholar : PubMed/NCBI
16	Liu F, Zhu Z, Mao Y, Liu M, Tang T and Qiu S: Inhibition of titanium particle-induced osteoclastogenesis through inactivation of NFATc1 by VIVIT peptide. Biomaterials. 30:1756–1762. 2009. View Article : Google Scholar : PubMed/NCBI
17	von Knoch M, Jewison DE, Sibonga JD, Sprecher C, Morrey BF, Loer F, Berry DJ and Scully SP: The effectiveness of polyethylene versus titanium particles in inducing osteolysis in vivo. J Orthop Res. 22:237–243. 2004. View Article : Google Scholar : PubMed/NCBI
18	Lee SS, Woo CH, Chang JD and Kim JH: Roles of Rac and cytosolic phospholipase A2 in the intracellular signalling in response to titanium particles. Cell Signal. 15:339–345. 2003. View Article : Google Scholar : PubMed/NCBI
19	Qin A, Cheng TS, Lin Z, Cao L, Chim SM, Pavlos NJ, Xu J, Zheng MH and Dai KR: Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption. PloS One. 7:e341322012. View Article : Google Scholar : PubMed/NCBI
20	Wedemeyer C, Xu J, Neuerburg C, Landgraeber S, Malyar NM, von Knoch F, Gosheger G, von Knoch M, Löer F and Saxler G: Particle-induced osteolysis in three-dimensional micro-computed tomography. Calcif Tissue Int. 81:394–402. 2007. View Article : Google Scholar : PubMed/NCBI
21	Cano E, Hazzalin CA and Mahadevan LC: Anisomycin-activated protein kinases p45 and p55 but not mitogen-activated protein kinases ERK-1 and -2 are implicated in the induction of c-fos and c-jun. Mol Cell Biol. 14:7352–7362. 1994. View Article : Google Scholar : PubMed/NCBI
22	Hazzalin CA, Le Panse R, Cano E and Mahadevan LC: Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction. Mol Cell Biol. 18:1844–1854. 1998. View Article : Google Scholar : PubMed/NCBI
23	Lin C, Shao Y, Zeng C, Zhao C, Fang H, Wang L, Pan J, Liu L, Qi W, Feng X, et al: Blocking PI3K/AKT signaling inhibits bone sclerosis in subchondral bone and attenuates post-traumatic osteoarthritis. J Cell Physiol. 233:6135–6147. 2018. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
25	Stevenson DA, Schwarz EL, Carey JC, Viskochil DH, Hanson H, Bauer S, Weng HY, Greene T, Reinker K, Swensen J, et al: Bone resorption in syndromes of the Ras/MAPK pathway. Clin Genet. 80:566–573. 2011. View Article : Google Scholar : PubMed/NCBI
26	Huang H, Chang EJ, Ryu J, Lee ZH, Lee Y and Kim HH: Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem Biophys Res Commun. 351:99–105. 2006. View Article : Google Scholar : PubMed/NCBI
27	Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS and Schett G: Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. Arthritis Rheum. 54:463–472. 2006. View Article : Google Scholar : PubMed/NCBI
28	Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature. 410:37–40. 2001. View Article : Google Scholar : PubMed/NCBI
29	Lucas JJ, Yamamoto A, Scearce-Levie K, Saudou F and Hen R: Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin 1B receptor knock-out mice. J Neurosci. 18:5537–5544. 1998. View Article : Google Scholar : PubMed/NCBI
30	Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, et al: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 3:889–901. 2002. View Article : Google Scholar : PubMed/NCBI
31	Sharma SM, Bronisz A, Hu R, Patel K, Mansky KC, Sif S and Ostrowski MC: MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation. J Biol Chem. 282:15921–15929. 2007. View Article : Google Scholar : PubMed/NCBI
32	Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K and Nogi Y: Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1. J Biol Chem. 279:45969–45979. 2004. View Article : Google Scholar : PubMed/NCBI
33	Kyriakis JM and Avruch J: Mammalian MAPK signal transduction pathways activated by stress and inflammation: A 10-year update. Physiol Rev. 92:689–737. 2012. View Article : Google Scholar : PubMed/NCBI
34	Hirakawa K, Bauer TW, Stulberg BN and Wilde AH: Comparison and quantitation of wear debris of failed total hip and total knee arthroplasty. J Biomed Mater Res. 31:257–263. 1996. View Article : Google Scholar : PubMed/NCBI
35	Baumann B, Seufert J, Jakob F, Nöth U, Rolf O, Eulert J and Rader CP: Activation of NF-kappaB signalling and TNFalpha-expression in THP-1 macrophages by TiAlV- and polyethylene-wear particles. J Orthop Res. 23:1241–1248. 2005.PubMed/NCBI
36	Masui T, Sakano S, Hasegawa Y, Warashina H and Ishiguro N: Expression of inflammatory cytokines, RANKL and OPG induced by titanium, cobalt-chromium and polyethylene particles. Biomaterials. 26:1695–1702. 2005. View Article : Google Scholar
37	Baumann B, Rader CP, Seufert J, Nöth U, Rolf O, Eulert J and Jakob F: Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. Acta Orthop Scand. 75:295–302. 2004. View Article : Google Scholar : PubMed/NCBI